The Enterprise Value as of July 2024 (TTM) for TG Therapeutics, Inc. (TGTX) is 3.21B

According to TG Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 3.21B. This represents a change of 41.87% compared to the average of 2.27B of the last 4 quarters.

TG Therapeutics, Inc. (TGTX) Historical Enterprise Value (quarterly & annually)

How has TGTX Enterprise Value performed in the past?

The mean historical Enterprise Value of TG Therapeutics, Inc. over the last ten years is 1.46B. The current 3.21B Enterprise Value has changed 21.90% with respect to the historical average. Over the past ten years (40 quarters), TGTX's Enterprise Value was at its highest in in the December 2020 quarter at 5.94B. The Enterprise Value was at its lowest in in the December 2016 quarter at 204.18M.

TG Therapeutics, Inc. (TGTX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of TG Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

TG Therapeutics, Inc. (TGTX) Average Enterprise Value

How has TGTX Enterprise Value performed in the past?

The current Enterprise Value of TG Therapeutics, Inc. (TGTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

TG Therapeutics, Inc. (TGTX) Enterprise Value vs. Peers

How is TGTX’s Enterprise Value compared to its peers?

TG Therapeutics, Inc.’s Enterprise Value is less than Madrigal Pharmaceuticals, Inc. (5.56B), greater than Intercept Pharmaceuticals, Inc. (915.81M), greater than Terns Pharmaceuticals, Inc. (518.07M), greater than Hepion Pharmaceuticals, Inc. (-8319926.00), less than Exelixis, Inc. (6.76B), less than Viking Therapeutics, Inc. (7.23B), greater than BioXcel Therapeutics, Inc. (71.36M), greater than Akero Therapeutics, Inc. (1.36B), less than Reata Pharmaceuticals, Inc. (6.68B), greater than X4 Pharmaceuticals, Inc. (142.54M), greater than PDS Biotechnology Corporation (99.79M),

Build a custom stock screener for TG Therapeutics, Inc. (TGTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like TG Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

TG Therapeutics, Inc. (TGTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like TG Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.